1 / 9

Scaffold Technology Market Insights - Industry Analysis and Forecast to 2024

Scaffold Technology Market Size & Forecast, By Product (Hydrogels, Micro-Patterned Surface Microplates, Polymeric & Nanofiber Scaffold), By Application, By End-Use And Trend Analysis From 2018 To 2024

Marsh
Download Presentation

Scaffold Technology Market Insights - Industry Analysis and Forecast to 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Scaffold Technology Market Analysis, Size, Growth, Share & Forecast to 2024 | Grand View Research Inc. “Scaffold Technology Market Projected To Be Worth $1.5 Billion By 2024” The global Scaffold Technology Market is anticipated to reach USD 1.5 billion by 2024, according to a new report by Grand View Research, Inc.Evolution of scaffold technology, which facilitates the transplantation process, has created opportunities to address tissue engineering-associated challenges such as vascularization. Also, scaffolds are used in the treatment of damaged and diseased organs or tissues to provide support to implants that are surgically inserted into the patient’s body. This is expected to further support the emergence of this vertical. Rise in the aging population and the number of organ defunctionalization cases coupled with the demand for effective treatments are some of the factors promoting the adoption of scaffold technology. Further Key Findings from the Study Suggest: In 2015, hydrogels-based scaffolds dominated the market with a share of over 41% with respect to revenue generation owing to their higher availability as well as continual progress in their development. Moreover, their promising use as cartilage tissue engineering scaffolds, which enable simultaneous cell growth and drug delivery, is fueling their adoption. • Even though nanofiber-based scaffolds are estimated to exhibit the lowest market penetration in the current scenario, this segment is expected to witness the fastest growth rate in the coming years due to their ability to mimic the nanoscale properties and structural characteristics of native extracellular matrix; this factor is expected to increase their incorporation in regenerative medicine and other clinical applications. • Follow Us:

  2. Biotechnology and pharmaceutical organizations held the largest share in 2015 and are expected to witness considerable growth over the forecast period due to the demand for robust tools in metabolic and toxicology profiling of drug moieties during the process of drug development. Also, several biotechnological companies have begun investing in the development of novel products targeting this vertical, which is expected to boost revenue generation through these entities. • In 2014, North America emerged as one of the largest markets. This is attributable to the developed healthcare infrastructure and presence of large number of key participants operating in this region. Asia pacific is expected to be one of the fastest growing regional segments owing to the rapidly improving infrastructure and favorable government initiatives pertaining to research and development in the pharmaceutical industry. • Some of the key players operating the market space include Merck KGaA (Sigma-Aldrich Co. LLC);Thermo Fisher Scientific, Inc.; 3D Biotek LLC; Molecular Matrix, Inc; ReproCELL Europe Ltd (Reinnervate); Xanofi; Pelo Biotech GmbH; Corning, Inc; Becton, Dickinson and Company; 3D Biomatrix; Avacta Life Sciences Limited; Nanofiber Solutions; NuVasive, Inc; Vericel Corporation; Molecular Partners; Acelity (LifeCell Corporation); and Medtronic (Covidien plc). • These players are undertaking different market strategies to maintain their dominance in the market. These strategic endeavors include new product development, acquisitions and mergers, partnerships, and global expansion efforts. • Scaffold technology is considered as the leading candidate employed to perform 3D-culture assays including high throughput screening, cell to matrix interactions, cell to cell interactions, cell migration assays, and transfections, which collectively accounted for the largest segment share in 2015 and is anticipated to witness lucrative growth in the coming years. The significant share is attributed to the increasing use of scaffold technology to study cellular behavior and understand the underlying mechanism of diseases. • Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/scaffold-technology- market Grand View Research has segmented the scaffold technology market on the basis of types, application, end use, and region: Global Outlook, by Type (Revenue, USD Million, 2013 - 2024) Hydrogels • Polymeric Scaffolds • Micro-patterned Surface Microplates • Nanofiber-based Scaffolds • Global Outlook, by Application (Revenue, USD Million, 2013 - 2024) Cancer • Follow Us:

  3. Tissue Engineering & Clinical Application • Drug development • Stem cell research • Others • Global Outlook, by End Use (Revenue, USD Million, 2013 - 2024) Biotechnology and Pharmaceutical Organizations • Research Laboratories and Institutes • Hospitals and Diagnostic Centers • Others • Regional Outlook (Revenue, USD Million, 2013 - 2024) North America • oU.S. oCanada Europe • oGermany oUK Asia Pacific • oChina oJapan Latin America • oBrazil MEA • oSouth Africa Table of Content Chapter 1 Research Methodology 1.1 Information Procurement 1.2 Data Analysis Follow Us:

  4. Chapter 2 Executive Summary Chapter 3 Market Variables, Trends& Scope 3.1 Market Segmentation & Scope 3.1.1 Market driver analysis 3.1.1.1 Rising demand for 3D cellular models in translational research 3.1.1.2 Increasing demand for body reconstruction procedures and tissue engineering 3.1.1.3 Technological advancement of scaffold technology 3.1.2 Market restraint analysis 3.1.2.1 Introduction of scaffold free technology for 3D cell culture 3.1.2.2 Lack of consistency in results generated 3.2 Penetration & Growth Prospect Mapping For Product, 2015 3.3 Scaffold Technology - SWOT Analysis, By Factor (political & legal, economic and technological) 3.4 Industry Analysis - Porter’s Chapter 4 Market Categorization 1: Product Estimates & Trend Analysis 4.1 Scaffold technology market: Product movement analysis 4.2 Hydrogels 4.2.1 Global hydrogels based scaffold technology market, 2013 - 2024 (USD Million) 4.3 Polymeric Scaffolds 4.3.1 Global polymeric scaffolds market, 2013 - 2024 (USD Million) 4.4 Micropatterned Surface Microplates 4.4.1 Global micropatterned surface microplates market, 2013 - 2024 (USD Million) 4.5 Nanofiber Scaffolds 4.5.1 Global nanofiber scaffolds market, 2013 - 2024 (USD Million) Chapter 5 Market Categorization 2: Application Estimates & Trend Analysis 5.1 Scaffold Technology Market: Application Movement Analysis 5.2 Cancer 5.2.1 Global cancer market, 2013 - 2024 (USD Million) 5.3 Tissue Engineering & Clinical Applications 5.3.1 Global tissue engineering & clinical applications market, 2013 - 2024 (USD Million) 5.4 Drug Development 5.4.1 Global drug development market, 2013 - 2024 (USD Million) 5.5 Stem Cell Research 5.5.1 Global stem cell research market, 2013 - 2024 (USD Million) Follow Us:

  5. 5.6 Others 5.6.1 Global other applications market, 2013 - 2024 (USD Million) Chapter 6 Market Categorization 3: End use Estimates & Trend Analysis 6.1 Scaffold Technology Market: End-use Movement Analysis 6.2 Biotechnology and Pharmaceutical Industries 6.2.1 Global biotechnology and pharmaceutical organizations market, 2013 - 2024 (USD Million) 6.3 Research laboratories and Institutes 6.3.1 Global research laboratories and institutes market, 2013 - 2024 (USD Million) 6.4 Hospitals and Diagnostic Centers 6.4.1 Global hospitals and diagnostic centers market, 2013 - 2024 (USD Million) 6.5 Others 6.5.1 Global other end-uses market, 2013 - 2024 (USD Million) Chapter 7 Market Categorization 4: Regional Estimates & Trend Analysis, by Product & Application 7.1 Scaffold Technology Market Share By Region, 2015 & 2024 7.2 North America 7.2.1 North America scaffold technology market, 2013 - 2024 (USD Million) 7.2.2 U.S. 7.2.2.1 U.S scaffold technology culture market, 2013 - 2024 (USD Million) 7.2.3 Canada 7.2.3.1 Canada scaffold technology market, 2013 - 2024 (USD Million) 7.3 Europe 7.3.1 Europe scaffold technology market, 2013 - 2024 (USD Million) 7.3.2 Germany 7.3.2.1 Germany scaffold technology market, 2013 - 2024 (USD Million) 7.3.3 UK 7.3.3.1 UK scaffold technology market, 2013 - 2024 (USD Million) 7.4 Asia Pacific 7.4.1 Asia Pacific scaffold technology market, 2013 - 2024 (USD Million) 7.4.2 Japan 7.4.2.1 Japan scaffold technology market, 2013 - 2024 (USD Million) 7.4.3 China 7.4.3.1 China scaffold technology market, 2013 - 2024 (USD Million) 7.5 Latin America 7.5.1 Latin America scaffold technology market, 2013 - 2024 (USD Million) Follow Us:

  6. 7.5.2 Brazil 7.5.2.1 Brazil scaffold technology market, 2013 - 2024 (USD Million) 7.6 Middle East & Africa 7.6.1 Middle East & Africa scaffold technology market, 2013 - 2024 (USD Million) 7.6.2 South Africa 7.6.2.1 South Africa 3D cell culture market, 2013 - 2024 (USD Million) Chapter 8 Competitive Landscape 8.1 Strategy framework 8.2 Market participation categorization 8.2.1 Merck KGaA Group 8.2.1.1 Company overview 8.2.1.1.1 Sigma-Aldrich Co. LLC 8.2.1.2 Financial performance 8.2.1.3 Product benchmarking 8.2.1.4 Strategic initiatives 8.2.2 Thermo Fisher Scientific, Inc. 8.2.2.1 Company overview 8.2.2.2 Financial performance 8.2.2.3 Product benchmarking 8.2.2.4 Strategic initiatives 8.2.3 3D Biotek LLC 8.2.3.1 Company overview 8.2.3.2 Financial performance 8.2.3.3 Product benchmarking 8.2.3.4 Strategic initiatives 8.2.4 Molecular Matrix Inc 8.2.4.1 Company overview 8.2.4.1 Financial Performance 8.2.4.2 Product benchmarking 8.2.4.3 Strategic initiatives 8.2.5 ReproCELL Europe Ltd (Reinnervate) 8.2.5.1 Company overview 8.2.5.2 Financial performance 8.2.5.3 Product benchmarking Follow Us:

  7. 8.2.5.4 Strategic initiatives 8.2.6 Xanofi 8.2.6.1 Company overview 8.2.6.2 Financial performance 8.2.6.3 Product benchmarking 8.2.6.4 Strategic initiatives 8.2.7 Tecan Trading AG. 8.2.7.1 Company overview 8.2.7.2 Financial performance 8.2.7.3 Product benchmarking 8.2.7.4 Strategic initiatives 8.2.8 Matricel GmbH 8.2.8.1 Company overview 8.2.8.2 Financial performance 8.2.8.3 Product benchmarking 8.2.8.4 Strategic initiatives 8.2.9 Pelo Biotech GmbH 8.2.9.1 Company overview 8.2.9.2 Financial performance 8.2.9.3 Product benchmarking 8.2.9.4 Strategic initiatives 8.2.10 Corning, Inc. 8.2.10.1 Company overview 8.2.10.2 Financial performance 8.2.10.3 Product benchmarking 8.2.10.4 Strategic initiatives 8.2.11 Akron Biotech 8.2.11.1 Company overview 8.2.11.2 Financial performance 8.2.11.3 Product benchmarking 8.2.11.4 Strategic initiatives 8.2.12 4titude 8.2.12.1 Company overview 8.2.12.2 Financial performance Follow Us:

  8. 8.2.12.3 Product benchmarking 8.2.12.4 Strategic initiatives 8.2.13 Becton, Dickinson and Company (BD) 8.2.13.1 Company overview 8.2.13.2 Financial performance 8.2.13.3 Product benchmarking 8.2.13.4 Strategic initiatives 8.2.14 3D Biomatrix 8.2.14.1 Company overview 8.2.14.2 Financial performance 8.2.14.3 Product benchmarking 8.2.14.4 Strategic initiatives 8.2.15 Avacta Life Sciences Limited 8.2.15.1 Company overview 8.2.15.2 Financial performance 8.2.15.3 Product benchmarking 8.2.15.4 Strategic initiatives 8.2.16 Nanofiber Solutions 8.2.16.1 Company overview 8.2.16.2 Financial performance 8.2.16.3 Product benchmarking 8.2.16.4 Strategic initiatives 8.2.17 NuVasive, Inc 8.2.17.1 Company overview 8.2.17.2 Financial performance 8.2.17.3 Product benchmarking 8.2.17.4 Strategic initiatives 8.2.18 Vericel Corporation 8.2.18.1 Company overview 8.2.18.2 Financial performance 8.2.18.3 Product benchmarking 8.2.18.4 Strategic initiatives 8.2.19 Molecular Partners 8.2.19.1 Company overview Follow Us:

  9. 8.2.19.2 Financial performance 8.2.19.3 Product benchmarking 8.2.19.4 Strategic initiatives 8.2.20 Acelity 8.2.20.1 Company overview 8.2.20.2 Financial performance 8.2.20.3 Product benchmarking 8.2.20.4 Strategic initiatives 8.2.21 Medtronic 8.2.21.1 Company overview 8.2.21.1.1 Covidien plc 8.2.21.2 Financial performance 8.2.21.3 Product benchmarking 8.2.21.4 Strategic initiatives About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email:sales@grandviewresearch.com For More Information:https://www.grandviewresearch.com Follow Us:

More Related